BG
Publications
84
Views
21,665
Downloads
7,423
Supervised works
1
Items per page
1 - 84 of 84
Title Published in Access level OA Policy Year Views Downloads
Is there a shift from cardiovascular to cancer death in lipid-lowering trials ? A systematic review and meta-analysisPloS one
accessLevelPublic
2024 1 0
Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitusFrontiers in cardiovascular medicine
accessLevelPublic
2024 38 4
Routine beta-blocker therapy after acute coronary syndromes : The end of an era ?European journal of clinical investigation
accessLevelPublic
2024 18 30
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-studyCatheterization and cardiovascular interventions
accessLevelRestricted
2024 4 0
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesAtherosclerosis plus
accessLevelPublic
2024 3 4
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndromeEuropean journal of preventive cardiology
accessLevelPublic
2024 59 73
Mid-term changes in cognitive functions in patients with atrial fibrillation : a longitudinal analysis of the Swiss-AF cohortFrontiers in cardiovascular medicine
accessLevelPublic
2023 56 40
Smoking cessation in people with and without diabetes after acute coronary syndromeNicotine & tobacco research
accessLevelPublic
2023 73 17
Improving atrial fibrillation outcomes through interclinician electronic consultationEuropean journal of clinical investigation
accessLevelPublic
2023 3 9
Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromesEuropean heart journal. Acute cardiovascular care
accessLevelPublic
2023 56 128
Management of dyslipidemia in patientswith cardiovascular disease”
accessLevelPublic
2023 102 21
« Heart Team » : le cœur de la cardiologieRevue médicale suisse
accessLevelPublic
2023 5 5
Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation : A prospective cohort studyInternational journal of stroke
accessLevelPublic
2023 66 61
Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation : Subanalysis of the VITAL StudyCirculation. Arrhythmia and electrophysiology
accessLevelPublic
2023 71 76
In-hospital initiation of PCSK9 inhibitors in ACS : pros and consEuroIntervention
accessLevelPublic
2023 94 102
Lipid-lowering trials are not representative of patients managed in clinical practice : a systematic review and meta-analysis of exclusion criteriaJournal of the American Heart Association. Cardiovascular and cerebrovascular disease
accessLevelPublic
2023 116 174
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroupsThe American heart journal
accessLevelPublic
2022 487 145
Challenges in the Management of Atrial Fibrillation With Subclinical HyperthyroidismFrontiers in endocrinology
accessLevelPublic
2022 233 120
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexCirculation
accessLevelRestricted
2022 230 27
Polypharmacie et medicaments inappropriés chez les patients âgés multimorbides - Ce que l’étude OPERAM nous apprend et va nous apprendreRevue médicale suisse
accessLevelRestricted
2022 197 0
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after studySwiss medical weekly
accessLevelPublic
2022 71 36
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndromeEuropean journal of preventive cardiology
accessLevelRestricted
2022 101 0
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)American heart journal
accessLevelPublic
2022 103 172
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of CardiologyEuropean journal of preventive cardiology
accessLevelRestricted
2022 256 0
Oméga-3 fortement dosés pour la prévention cardiovasculaire : une fausse bonne idée ?Revue médicale suisse
accessLevelRestricted
2022 299 1
2021 European guidelines on cardiovascular prevention: Challenges for an evidence-based patient careEuropean journal of clinical investigation
accessLevelRestricted
2022 208 1
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive CareEuropean heart journal. Quality of care & clinical outcomes
accessLevelPublic
2022 69 242
Renal dysfunction and outcome in left ventricular non-compactionCardiology Journal
accessLevelPublic
2022 85 109
Inclisiran in primary prevention : reality or fiction ?European heart journal
accessLevelRestricted
2022 129 0
Impact of malignancy on clinical outcomes in patients with acute coronary syndromesInternational journal of cardiology
accessLevelRestricted
2021 184 0
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in SwitzerlandPreventive medicine reports
accessLevelPublic
2021 200 111
Prognostic value of total testosterone levels in patients with acute coronary syndromesEuropean Journal of Preventive Cardiology
accessLevelRestricted
2021 485 3
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse eventsAtherosclerosis
accessLevelPublic
2021 222 42
Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromesEuropean heart journal. Acute cardiovascular care
accessLevelPublic
2021 188 208
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary SyndromesJournal of the American Heart Association
accessLevelPublic
2021 207 105
Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failureReviews in endocrine and metabolic disorders
accessLevelPublic
2021 210 160
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patientsAtherosclerosis
accessLevelPublic
2021 164 45
Air pollution triggers inflammation and cardiovascular events: now is the time to actEuropean heart journal
accessLevelRestricted
2021 160 0
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelinesEuropean journal of preventive cardiology
accessLevelRestricted
2021 162 0
Improving 1-year mortality prediction in ACS patients using machine learningEuropean heart journal. Acute cardiovascular care
accessLevelRestricted
2021 172 1
Dynamical analysis in a self-regulated system undergoing multiple excitations: first order differential equation approachMultivariate Behavioral Research
accessLevelPublic
2021 236 215
Antibodies against apolipoprotein a-1 as disruptors of cellular cholesterol homeostasis promoting foam cell formation88th EAS (European Atherosclerosis Society) Congress
2020 60 0
Optimal timing of invasive coronary angiography following NSTEMIJournal of interventional cardiology
accessLevelPublic
2020 234 110
Emerging Concepts and Applied Machine Learning Research in Patients with Drug-Induced Repolarization DisordersStudies in Health Technology and Informatics
accessLevelPublic
2020 498 186
Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trialJAMA cardiology
accessLevelPublic
2020 280 329
Cognition After Lowering LDL-Cholesterol With EvolocumabJournal of the American College of Cardiology
accessLevelRestricted
2020 155 0
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyEuropean heart journal. Acute cardiovascular care
accessLevelRestricted
2020 179 0
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous ThromboembolismCirculation
accessLevelPublic
2020 238 132
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortInternational journal of cardiology
accessLevelRestricted
2020 220 0
Prognosis of patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary SyndromesJournal of cardiovascular translational research
accessLevelPublic
2020 169 102
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitorsInternational journal of cardiology
accessLevelRestricted
2020 159 0
Potential of lipoprotein(a)-lowering strategies in treating coronary artery diseaseDrugs
accessLevelRestricted
2020 180 0
C-terminus apoa-1 mimetic peptides to detect cognate auto-antibodies and reverse HIV-induced foam cell formationAtherosclerosis
accessLevelRestricted
2020 248 0
The Impact of Levothyroxine on Cardiac Function in Older Adults With Mild Subclinical Hypothyroidism: A Randomized Clinical TrialThe American journal of medicine
accessLevelPublic
2020 227 138
Right ventricle and outcome in left ventricular non-compaction cardiomyopathyJournal of cardiology
accessLevelPublic
2020 167 99
Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiographyCatheterization and Cardiovascular Interventions
accessLevelRestricted
2019 318 0
Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohortAtherosclerosis
accessLevelRestricted
2019 433 1
Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromesJournal of Clinical Medicine
accessLevelPublic
2019 435 173
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromesEuropean Journal of Clinical Investigation
accessLevelRestricted
2019 397 2
Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell FormationJournal of clinical medicine
accessLevelPublic
2019 238 150
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionPloS one
accessLevelPublic
2019 55 58
Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized TrialThe journal of clinical endocrinology and metabolism
accessLevelPublic
2018 463 98
Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patientsJournal of Infection
accessLevelRestricted
2018 577 1
Impact of long distance rowing on biological health: A pilot studyClinical Biochemistry
accessLevelRestricted
2018 562 0
Etat des connaissances en 2018 sur les anticorps anti-PCSK9Revue médicale suisse
accessLevelPublic
2018 232 94
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 updateEuropean heart journal
accessLevelPublic
2018 235 137
Inhibiteurs de PCSK9Forum médical suisse
accessLevelPublic
2017 202 53
Multi-organ injuries due to a lightning strike: a case report highlighting the importance of a multi-disciplinary approachCase reports in plastic surgery & hand surgery
accessLevelPublic
2017 551 249
The fear of dying and occurrence of posttraumatic stress symptoms after an acute coronary syndrome: A prospective observational studyJournal of health psychology
accessLevelPublic
2017 551 616
The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenationInternational journal of cardiology
accessLevelRestricted
2016 635 0
A Randomized Study of SheathLess vs Standard Guiding Catheters for Transradial Percutaneous Coronary InterventionsCanadian journal of cardiology
2016 551 0
Prognostic value of PCSK9 levels in patients with acute coronary syndromesEuropean heart journal
accessLevelRestricted
2016 628 2
Health utility indexes in patients with acute coronary syndromesOpen heart
accessLevelPublic
2016 559 260
Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of StayPloS one
accessLevelPublic
2016 853 366
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial proceduresEuropean Journal of Internal Medicine
accessLevelRestricted
2016 505 1
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy populationEuropean journal of clinical investigation
accessLevelRestricted
2015 656 0
Use and role of monoclonal antibodies and other biologics in preventive cardiologySchweizerische medizinische Wochenschrift
accessLevelPublic
2015 657 307
Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness AnalysisPloS one
accessLevelPublic
2015 520 306
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromesAtherosclerosis
accessLevelPublic
2015 784 539
La testostérone : un traitement pour la prévention des maladies cardiovasculaires ?Revue médicale suisse
accessLevelRestricted
2014 500 0
Subclinical Thyroid Dysfunction and Cardiovascular Outcomes among Prospective Cohort StudiesEndocrine, metabolic & immune disorders. Drug targets.
accessLevelPublic
2013 178 199
Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and MortalityArchives of internal medicine
accessLevelPublic
2012 170 51
Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: an individual participant data analysis from 6 prospective cohortsCirculation
accessLevelPublic
2012 201 100
Quels niveaux de cholestérol devrait-on traiter en Suisse?Forum médical suisse
accessLevelPublic
2011 182 77
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack